胃腺癌化学療法中に原発巣増大をきたし混合型腺神経内分泌腫瘍と診断した 1 例

Translated title of the contribution: A case of mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) diagnosed by re-biopsy of the enlarged primary tumor during chemotherapy for gastric adenocarcinoma

Mayo Fuchino*, Atsuko Nakaya, Takayuki Ando, Yuushi Hasumoto, Koji Ozawa, Hiroyuki Ito, Kazuhisa Yabushita, Shigeharu Miwa, Shinichi Hayashi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Gastric mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) is an extremely rare form of gastric neoplasm, and its prognosis is often poor. This is a case report wherein the primary site increased during chemotherapy against gastric adenocarcinoma and was diagnosed with gastric MiNEN after total gastrectomy. A 71-year-old man was diagnosed with gastric adenocarcinoma complicated with liver and para-aortic lymph node metastasis. Chemotherapy with S-1, oxaliplatin, and trastuzumab was initiated. Although the size of metastatic lesions was reduced after six courses of treatment, a part of the primary site of gastric tumor rapidly. Pathological rebiopsy of the primary site suggested a neuroendocrine carcinoma, and he was finally diagnosed with gastric MiNEN after total gastrectomy. Thus, second-line chemotherapy was then initiated showing good response. We herein report a case of MiNEN with a rare diagnostic process.

Translated title of the contributionA case of mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) diagnosed by re-biopsy of the enlarged primary tumor during chemotherapy for gastric adenocarcinoma
Original languageJapanese
Pages (from-to)55-62
Number of pages8
JournalJournal of Japanese Society of Gastroenterology
Volume121
Issue number1
DOIs
StatePublished - 2024

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint

Dive into the research topics of 'A case of mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) diagnosed by re-biopsy of the enlarged primary tumor during chemotherapy for gastric adenocarcinoma'. Together they form a unique fingerprint.

Cite this